[an error occurred while processing this directive]

Journal of Integrative Medicine ›› 2025, Vol. 23 ›› Issue (1): 36-45.doi: 10.1016/j.joim.2024.11.004

• Original Clinical Research • Previous Articles     Next Articles

How are different traditional Chinese medicine modalities deployed by clinical practitioners in China? Findings from a national survey

Ran Guoa, Dian Zengb, Qi Zhaoc, Xin-yi Zhanga, Xiao-ke Zhanga, Yuan-li Liua   

  1. a. School of Health Policy and Management, Peking Union Medical College, Beijing 100010, China
    b. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China c. Office of Hospital Affairs, Chinese Academy of Medical Sciences & Peking Union of Medical College, Beijing 100730, China
  • Received:2024-04-02 Accepted:2024-06-11 Online:2025-01-20 Published:2024-11-22
  • Contact: Yuan-li Liu E-mail:liuyuanli_pumc@163.com

Objective

Traditional Chinese medicine (TCM) incorporates traditional diagnostic methods and several major treatment modalities including Chinese herbal medicine, Chinese patent medicine, and non-pharmacological methods such as acupuncture and tuina. Even though TCM is used daily by more than 70,000 healthcare facilities and over 700,000 clinical practitioners in China, there is a poor understanding of the extent to which TCM diagnostic methods are used, how different treatment modalities are deployed in general, and what major factors may affect the integration of TCM and Western medicine. This study aimed to fill this void in the literature.

Methods

In the 2021 National Healthcare Improvement Evaluation Survey, we included three questions gauging the perception and practices of TCM amongst physicians working in TCM-related facilities, investigating the frequency of their deployment of TCM diagnostic methods, and predominant TCM treatment methods. Our empirical analysis included descriptive statistics, intergroup chi-square analysis, and binary logistic regression to examine the association between different types of facilities and individual characteristics and TCM utilization patterns.

Results

A total of 7618 clinical physicians comprised our study sample. Among them, 84.27% have integrated TCM and Western medicine in their clinical practice, and 80.77% of TCM practitioners used the 4 diagnostic methods as a tool in their clinical practice. Chinese herbal medicine was the most widely utilized modality by Chinese TCM physicians (used by 88.49% of respondents), compared with the Chinese patent medicine and non-pharmacological TCM methods, which were used by 73.14%, and 69.39%, respectively. Herbal tea as an out-of-pocket health-maintenance intervention is also a notable practice, recommended by 29.43% of physicians. Significant variations exist across certain institutions, departments, and individual practitioners.

Conclusion

Given that most of the surveyed physicians integrated TCM with Western medicine in their clinical practices, the practice of “pure TCM” appears to be obsolete in China’s tertiary healthcare institutions. Notably, remarkable variation exists in the use of different TCM modalities across institutions and among individuals, which might be related to and thus limited by the practitioners’ experience. Future research focusing on the efficacy and safety of TCM interventions for specific diseases, the development of standardized clinical guidelines, and the enhancement of TCM education and training are called for to optimize TCM-Western medicine integration.

Key words: Traditional Chinese medicine, Clinical modalities, Deployment

[1] Yan Han, Yu Wang, Mo-yi Shi, Yu Liu, Xiao-dong Cheng, Yang Zhou. Integrating traditional Chinese medicine constitutions into insomnia management: Findings from a cross-sectional study. Journal of Integrative Medicine, 2025, 23(4): 382-389.
[2] Ya-ting Ai, Shi Zhou, Ming Wang, Tao-yun Zheng, Hui Hu, Yun-cui Wang, Yu-can Li, Xiao-tong Wang, Peng-jun Zhou. Development of a machine learning-based risk prediction model for mild cognitive impairment with spleen-kidney deficiency syndrome in the elderly. Journal of Integrative Medicine, 2025, 23(4): 390-397.
[3] Man Liao, Li-ting Zhang, Li-juan Bai, Rui-yun Wang, Yun Liu, Jing Han, Li-hua Liu, Ben-ling Qi. Xuebijing injection reduces COVID-19 patients’ mortality as influenced by the neutrophil to lymphocyte platelet ratio. Journal of Integrative Medicine, 2025, 23(3): 282-288.
[4] Cheng Zhang, Yi-sen Nie, Chuan-tao Zhang, Hong-jing Yang, Hao-ran Zhang, Wei Xiao, Guang-fu Cui, Jia Li, Shuang-jing Li, Qing-song Huang, Shi-yan Yan. An adaptive Bayesian randomized controlled trial of traditional Chinese medicine in progressive pulmonary fibrosis: Rationale and study design. Journal of Integrative Medicine, 2025, 23(2): 138-144.
[5] Shi-yun Yan. Thoughts on the construction of flagship hospitals of integrated traditional Chinese and Western medicine in China. Journal of Integrative Medicine, 2025, 23(1): 12-14.
[6] Xuan Yin, Zhu Jin, Feng Li, Li Huang, Yan-mei Hu, Bo-chang Zhu, Zu-qing Wang, Xi-ying Li, Jian-ping Li, Lixing Lao, Yi-qun Mi, Shi-fen Xu. Effectiveness and safety of adjunctive non-drug measures in improving respiratory symptoms among patients with severe COVID-19: A multicenter randomized controlled trial. Journal of Integrative Medicine, 2024, 22(6): 637-644.
[7] Yuan He, Xiao-xuan Qin, Ming-wei Liu, Wei Sun. Morin, a matrix metalloproteinase 9 inhibitor, attenuates endothelial-to-mesenchymal transition in atherosclerosis by downregulating Notch-1 signaling. Journal of Integrative Medicine, 2024, 22(6): 683-695.
[8] Qiong Zhang, Ying-yi Fan, Xue-qing Wu, Yan-dan Huo, Chun-hui Wang, Shi-bing Liang, Ting Wang, Rong Zhong, Xuan Wang, Bao-yong Lai, Xiao-hua Pei, Jian-ping Liu. Hongjin Xiaojie Capsule, a Chinese patent medicine, for treating moderate to severe cyclical breast pain: A single-blind randomized controlled trial. Journal of Integrative Medicine, 2024, 22(5): 552-560.
[9] Hui-zhi Zhu, Cheng-yi Li, Liang-ji Liu, Jia-bing Tong, Zhi-hui Lan, Shu-guang Tian, Qiao Li, Xiang-li Tong, Ji-feng Wu, Zhen-gang Zhu, Su-yun Li, Jian-sheng Li. Efficacy and safety of Qingfei Huatan formula in the treatment of acute exacerbation of chronic obstructive pulmonary disease: A multi-centre, randomised, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2024, 22(5): 561-569.
[10] Ya-nan Yang, Jia-guo Zhan, Ying Cao, Chong-ming Wu. From ancient wisdom to modern science: Gut microbiota sheds light on property theory of traditional Chinese medicine. Journal of Integrative Medicine, 2024, 22(4): 413-444.
[11] Tong-yi Zhou, Na Tian, Liu Li, Rong Yu. Iridoids modulate inflammation in diabetic kidney disease: A review. Journal of Integrative Medicine, 2024, 22(3): 210-222.
[12] Peng Wang, Jing Hong, Zhu-qian Tang, Bi-zhen Gong, Xiao-rong Qi, Han Jiang, Bo Pan, Qi Chen. The acceptance of traditional Chinese medicine among patients with Parkinson's disease: A hospital survey. Journal of Integrative Medicine, 2024, 22(2): 180-187.
[13] Jun-yan He, Xiao-yu Tu, Zi-fei Yin, Hui Mu, Ming-jun Luo, Xing-yu Chen, Wei-bin Cai, Xue Zhao, Can Peng, Fan-fu Fang, Can Lü, Bai Li. Short-term effects of cupping and scraping therapy for chronic nonspecific low-back pain: A prospective, multicenter randomized trial. Journal of Integrative Medicine, 2024, 22(1): 39-45.
[14] Monika Rybicka, Jing Zhao, Karolina Piotrowicz, Sara Ptasnik, Kamila Mitka, Magdalena Kocot-Kępska, Ka-Kit Hui. Promoting whole person health: Exploring the role of traditional Chinese medicine in Polish healthcare. Journal of Integrative Medicine, 2023, 21(6): 509-517.
[15] Xiao-cong Wang, Xiao-yu Liu, Kang-le Shi, Qing-gang Meng, Yue-fan Yu, Shi-yao Wang, Juan Wang, Chang Qu, Cong Lei, Xin-ping Yu. Blinding assessment in clinical trials of traditional Chinese medicine: Exploratory principles and protocol. Journal of Integrative Medicine, 2023, 21(6): 528-536.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[an error occurred while processing this directive]